Digestive & Intestinal Remedies (Pharmacies) - Bolivia

  • Bolivia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$10.17m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.97%, resulting in a market volume of US$11.77m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.81 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Bolivia has been experiencing steady growth in recent years.

Customer preferences:
Bolivian customers have shown a growing preference for Digestive & Intestinal Remedies (Pharmacies) products in recent years. This can be attributed to several factors. Firstly, there is a growing awareness among Bolivians about the importance of digestive health and the role that these remedies can play in maintaining a healthy digestive system. Secondly, the increasing availability and accessibility of these products in pharmacies across the country has made it easier for customers to purchase them. Lastly, the rising incidence of digestive disorders and gastrointestinal issues in Bolivia has also contributed to the growing demand for these remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Bolivia is the increasing popularity of natural and herbal remedies. Bolivian customers are increasingly looking for products that are made from natural ingredients and have fewer side effects. This trend is in line with the global shift towards natural and organic products, as customers become more conscious about the potential risks associated with synthetic medications. As a result, we have seen an increase in the availability of natural digestive remedies in pharmacies across Bolivia. Another trend in the market is the growing demand for probiotics. Probiotics are live bacteria and yeasts that are good for your health, especially your digestive system. They are commonly found in yogurts and other fermented foods, but are also available in supplement form. Bolivian customers have shown a growing interest in probiotics, as they are believed to promote a healthy balance of bacteria in the gut and improve digestion. This trend is in line with the global rise in probiotic consumption, as customers become more aware of the potential benefits of these products.

Local special circumstances:
One of the unique factors influencing the Digestive & Intestinal Remedies (Pharmacies) market in Bolivia is the country's traditional medicine practices. Bolivia has a rich tradition of herbal medicine, with many indigenous communities relying on traditional remedies for their healthcare needs. This has influenced the preferences of Bolivian customers, who often seek out natural and herbal remedies for their digestive health issues. As a result, there is a strong demand for traditional herbal remedies in the Digestive & Intestinal Remedies (Pharmacies) market in Bolivia.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies (Pharmacies) market in Bolivia can also be attributed to the country's improving economy and rising disposable incomes. As the Bolivian economy continues to grow, more people have the means to purchase healthcare products, including digestive remedies. This has led to an increase in demand for these products in the market. Additionally, the government's focus on improving healthcare infrastructure and access to healthcare services has also contributed to the growth of the market, as more people are able to seek treatment for their digestive health issues.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)